NO931151L - Fremgangsmaate for fremstilling av nitrogenholdige heterocykliske forbindelser med kondenserte ringer - Google Patents
Fremgangsmaate for fremstilling av nitrogenholdige heterocykliske forbindelser med kondenserte ringerInfo
- Publication number
- NO931151L NO931151L NO93931151A NO931151A NO931151L NO 931151 L NO931151 L NO 931151L NO 93931151 A NO93931151 A NO 93931151A NO 931151 A NO931151 A NO 931151A NO 931151 L NO931151 L NO 931151L
- Authority
- NO
- Norway
- Prior art keywords
- nitrogen containing
- procedure
- preparation
- containing heterocyclic
- heterocyclic compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Eye Examination Apparatus (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Electroluminescent Light Sources (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59042390A | 1990-09-28 | 1990-09-28 | |
PCT/US1991/005776 WO1992006079A1 (en) | 1990-09-28 | 1991-08-20 | Fused ring analogs of nitrogen containing nonaromatic heterocycles |
Publications (2)
Publication Number | Publication Date |
---|---|
NO931151D0 NO931151D0 (no) | 1993-03-26 |
NO931151L true NO931151L (no) | 1993-03-26 |
Family
ID=24362216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO93931151A NO931151L (no) | 1990-09-28 | 1993-03-26 | Fremgangsmaate for fremstilling av nitrogenholdige heterocykliske forbindelser med kondenserte ringer |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0550635B1 (de) |
JP (1) | JPH0772175B2 (de) |
CN (1) | CN1060285A (de) |
AT (1) | ATE121389T1 (de) |
AU (1) | AU651145B2 (de) |
BR (1) | BR9106905A (de) |
CA (1) | CA2089736A1 (de) |
CZ (1) | CZ387492A3 (de) |
DE (1) | DE69109125T2 (de) |
DK (1) | DK0550635T3 (de) |
ES (1) | ES2071334T3 (de) |
FI (1) | FI931370A (de) |
HU (1) | HUT68667A (de) |
IE (1) | IE66042B1 (de) |
IL (1) | IL99525A0 (de) |
MX (1) | MX9101274A (de) |
NO (1) | NO931151L (de) |
PT (1) | PT99064A (de) |
TW (1) | TW199144B (de) |
WO (1) | WO1992006079A1 (de) |
YU (1) | YU159291A (de) |
ZA (1) | ZA917744B (de) |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5716965A (en) * | 1991-05-22 | 1998-02-10 | Pfizer Inc. | Substituted 3-aminoquinuclidines |
DE69213451T2 (de) * | 1991-06-20 | 1997-01-09 | Pfizer Inc., New York | Fluoralkoxybenzylaminoderivate stickstoffhaltiger heterocyclen |
TW202432B (de) * | 1991-06-21 | 1993-03-21 | Pfizer | |
MY110227A (en) * | 1991-08-12 | 1998-03-31 | Ciba Geigy Ag | 1-acylpiperindine compounds. |
EP0533280B2 (de) * | 1991-09-20 | 2004-12-01 | Glaxo Group Limited | Neue medizinische Indikation für Tachykinin-Antagonisten |
DK0613458T3 (da) * | 1991-11-12 | 1998-02-09 | Pfizer | Acykliske ethylendiaminderivater som substans P receptorantagonister |
US5498614A (en) * | 1992-05-18 | 1996-03-12 | Pfizer Inc. | Bridged aza-bicyclic derivatives as substance P antagonist |
US5637699A (en) * | 1992-06-29 | 1997-06-10 | Merck & Co., Inc. | Process for preparing morpholine tachykinin receptor antagonists |
US6048859A (en) * | 1992-06-29 | 2000-04-11 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
US5719147A (en) * | 1992-06-29 | 1998-02-17 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
US5688804A (en) * | 1992-08-04 | 1997-11-18 | Pfizer Inc. | 3-Benzylamino-2-phenyl-piperidine derivatives as substance P receptor antagonists |
GB9216911D0 (en) * | 1992-08-10 | 1992-09-23 | Merck Sharp & Dohme | Therapeutic agents |
ES2164072T3 (es) * | 1992-08-19 | 2002-02-16 | Pfizer | Heterociclos no aromaticos que contienen nitrogeno sustituidos con bencilamino. |
US5387595A (en) * | 1992-08-26 | 1995-02-07 | Merck & Co., Inc. | Alicyclic compounds as tachykinin receptor antagonists |
ES2147759T3 (es) * | 1992-12-10 | 2000-10-01 | Pfizer | Heterociclos no aromaticos sustituidos con aminometileno y uso como antagonistas de la sustancia p. |
US5344830A (en) * | 1992-12-10 | 1994-09-06 | Merck & Co., Inc. | N,N-diacylpiperazine tachykinin antagonists |
US5830854A (en) * | 1992-12-14 | 1998-11-03 | Merck Sharp & Dohme, Limited | Method of treating cystic fibrosis using a tachykinin receptor antagonist |
US5340826A (en) * | 1993-02-04 | 1994-08-23 | Pfizer Inc. | Pharmaceutical agents for treatment of urinary incontinence |
US5393762A (en) * | 1993-06-04 | 1995-02-28 | Pfizer Inc. | Pharmaceutical agents for treatment of emesis |
US5854262A (en) * | 1993-10-07 | 1998-12-29 | Pfizer Inc. | Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists |
US5610165A (en) * | 1994-02-17 | 1997-03-11 | Merck & Co., Inc. | N-acylpiperidine tachykinin antagonists |
IL112778A0 (en) * | 1994-03-04 | 1995-05-26 | Merck & Co Inc | Substituted heterocycles, their preparation and pharmaceutical compositions containing them |
TW397825B (en) * | 1994-10-14 | 2000-07-11 | Novartis Ag | Aroyl-piperidine derivatives |
FR2725900B1 (fr) * | 1994-10-21 | 1997-07-18 | Sanofi Sa | Utilisation d'antagonistes des recepteurs nk1 pour la preparation de medicaments a action cardioregulatrice |
TW458774B (en) | 1995-10-20 | 2001-10-11 | Pfizer | Antiemetic pharmaceutical compositions |
US6048900A (en) * | 1998-02-13 | 2000-04-11 | Bayer Corporation | Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists |
JP2000510870A (ja) * | 1997-02-14 | 2000-08-22 | バイエル・コーポレーシヨン | Npy5受容体アンタゴニストとしてのアミド類 |
US6245817B1 (en) | 1997-02-14 | 2001-06-12 | Bayer Corporation | NPY5 receptor antagonists and methods for using same |
AU6144098A (en) * | 1997-02-14 | 1998-09-08 | Bayer Corporation | Amide derivatives as selective neuropeptide y receptor antagonists |
CA2389306C (en) | 1999-11-03 | 2010-03-30 | Albany Molecular Research, Inc. | Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
US7163949B1 (en) | 1999-11-03 | 2007-01-16 | Amr Technology, Inc. | 4-phenyl substituted tetrahydroisoquinolines and use thereof |
US7119207B2 (en) | 2000-04-10 | 2006-10-10 | Pfizer Inc | Benzoamide piperidine containing compounds and related compounds |
OA12245A (en) * | 2000-04-10 | 2003-11-10 | Pfizer Prod Inc | Benzoamide piperidine compounds as substance P antagonists. |
CA2415532C (en) | 2000-07-11 | 2010-05-11 | Albany Molecular Research, Inc. | Novel 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof |
EP1324994A4 (de) * | 2000-10-10 | 2004-06-16 | Calyx Therapeutics Inc | Tricyclische verbindungen und deren verwendungen |
MX2007000428A (es) | 2004-07-15 | 2008-03-05 | Amr Technology Inc | Tetrahidroisoquinolinas sustituidas con arilo y heteroarilo y uso de las mismas para bloquear la captacion de norepinefrina, dopamina y serotonina. |
ES2382814T3 (es) | 2005-05-17 | 2012-06-13 | Merck Sharp & Dohme Ltd. | Ácido cis-4-[(4-clorofenil)sulfonil]-4-(2,5-difluorofenil)ciclohexanopropanoico para el tratamiento del cáncer |
DE102005027168A1 (de) * | 2005-06-13 | 2006-12-14 | Merck Patent Gmbh | Tetrahydrochinoline |
MX2008000717A (es) | 2005-07-15 | 2008-03-18 | Amr Technology Inc | Tetrahidrobenzazepinas substituidas con arilo y heteroarilo y uso de las mismas para bloquear la reabsorcion de norepinefrina, dopamina, y serotonina. |
BRPI0616463A2 (pt) | 2005-09-29 | 2011-06-21 | Merck & Co Inc | composto, composição farmacêutica, e, uso de um composto |
GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
GB0617867D0 (en) * | 2006-09-11 | 2006-10-18 | Glaxo Group Ltd | Chemical compounds |
EP2946778A1 (de) | 2006-09-22 | 2015-11-25 | Merck Sharp & Dohme Corp. | Behandlungsverfahren mit verwendung von fettsäuresyntheseinhibitoren |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
KR101591656B1 (ko) | 2007-01-10 | 2016-02-19 | 엠에스디 이탈리아 에스.알.엘. | 폴리(adp-리보오스) 폴리머라아제(parp) 억제제로서의 아미드 치환된 인다졸 |
EA200970706A1 (ru) | 2007-01-24 | 2010-02-26 | Глэксо Груп Лимитед | Новые фармацевтические композиции |
JP5319518B2 (ja) | 2007-04-02 | 2013-10-16 | Msd株式会社 | インドールジオン誘導体 |
WO2009002495A1 (en) | 2007-06-27 | 2008-12-31 | Merck & Co., Inc. | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
GB0716573D0 (en) * | 2007-08-24 | 2007-10-03 | Glaxo Group Ltd | Chemical compounds |
AU2009222122A1 (en) | 2008-03-03 | 2009-09-11 | Tiger Pharmatech | Tyrosine kinase inhibitors |
GB0804326D0 (en) * | 2008-03-07 | 2008-04-16 | Glaxo Group Ltd | Novel compounds |
AR071997A1 (es) | 2008-06-04 | 2010-07-28 | Bristol Myers Squibb Co | Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina |
US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
UA105182C2 (ru) | 2008-07-03 | 2014-04-25 | Ньюрексон, Інк. | Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность |
EP2413932A4 (de) | 2009-04-01 | 2012-09-19 | Merck Sharp & Dohme | Hemmer der akt-aktivität |
CN102638982B (zh) | 2009-05-12 | 2015-07-08 | 百时美施贵宝公司 | (S)-7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉的晶型及其用途 |
DK2429296T3 (en) | 2009-05-12 | 2018-03-12 | Albany Molecular Res Inc | 7 - ([1,2,4,] TRIAZOLO [1,5, -A] PYRIDIN-6-YL) -4- (3,4-DICHLORPHENYL) -1,2,3,4- TETRAHYDROISOQUINOLINE AND USE thereof |
US9034899B2 (en) | 2009-05-12 | 2015-05-19 | Albany Molecular Research, Inc. | Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof |
EP2488028B1 (de) | 2009-10-14 | 2020-08-19 | Merck Sharp & Dohme Corp. | Substituierte piperidine zur erhöhung der p53-aktivität und ihre verwendung |
EP2584903B1 (de) | 2010-06-24 | 2018-10-24 | Merck Sharp & Dohme Corp. | Neue heterozyklische verbindungen als erk-hemmer |
WO2012018754A2 (en) | 2010-08-02 | 2012-02-09 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
AU2011292261B2 (en) | 2010-08-17 | 2015-05-14 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of Hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA) |
WO2012027236A1 (en) | 2010-08-23 | 2012-03-01 | Schering Corporation | NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
US8946216B2 (en) | 2010-09-01 | 2015-02-03 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as ERK inhibitors |
US9242981B2 (en) | 2010-09-16 | 2016-01-26 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel ERK inhibitors |
ES2663009T3 (es) | 2010-10-29 | 2018-04-10 | Sirna Therapeutics, Inc. | Inhibición de la expresión génica mediada por interferencia por ARN utilizando ácidos nucleicos de interferencia cortos (ANic) |
WO2012087772A1 (en) | 2010-12-21 | 2012-06-28 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
EP2699568A1 (de) | 2011-04-21 | 2014-02-26 | Piramal Enterprises Limited | Kristalline form eines morpholinsulfonylindolderivat-salzes und verfahren zu seiner herstellung |
EP2770987B1 (de) | 2011-10-27 | 2018-04-04 | Merck Sharp & Dohme Corp. | Neue verbindungen als erk-hemmer |
WO2013165816A2 (en) | 2012-05-02 | 2013-11-07 | Merck Sharp & Dohme Corp. | SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS |
WO2014052563A2 (en) | 2012-09-28 | 2014-04-03 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
CA2891122C (en) | 2012-11-14 | 2021-07-20 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
CA2892361A1 (en) | 2012-11-28 | 2014-06-05 | Merck Sharp & Dohme Corp. | Use of a wee1 inhibitor for treating a cancer characterized by low pkmyt1 expression levels |
AU2013361694B2 (en) | 2012-12-20 | 2017-10-26 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as HDM2 inhibitors |
WO2014120748A1 (en) | 2013-01-30 | 2014-08-07 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as hdm2 inhibitors |
WO2015034925A1 (en) | 2013-09-03 | 2015-03-12 | Moderna Therapeutics, Inc. | Circular polynucleotides |
CN104610146A (zh) * | 2015-01-23 | 2015-05-13 | 常州大学 | 一种3-氮杂二环[5,1,0]-7-醛及合成方法 |
CN105330588B (zh) * | 2015-10-16 | 2017-09-26 | 辽宁中医药大学 | 马齿苋中生物碱Oleracone及其提取分离方法 |
EP3706742B1 (de) | 2017-11-08 | 2023-03-15 | Merck Sharp & Dohme LLC | Prmt5-inhibitoren |
US11981701B2 (en) | 2018-08-07 | 2024-05-14 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
WO2020033282A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
CN113121427B (zh) * | 2021-03-19 | 2022-04-01 | 广东工业大学 | 一种喹啉类衍生物及其制备方法和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3452026A (en) * | 1966-03-15 | 1969-06-24 | Bristol Myers Co | Substituted 1,2,3,4-tetrahydroquinolines |
FR1555552A (de) * | 1967-07-05 | 1969-01-31 | ||
US4198415A (en) * | 1979-01-22 | 1980-04-15 | Eli Lilly And Company | Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines |
MX18467A (es) * | 1988-11-23 | 1993-07-01 | Pfizer | Agentes terapeuticos de quinuclidinas |
-
1991
- 1991-08-20 EP EP91918058A patent/EP0550635B1/de not_active Expired - Lifetime
- 1991-08-20 CZ CS923874A patent/CZ387492A3/cs unknown
- 1991-08-20 AU AU87463/91A patent/AU651145B2/en not_active Expired - Fee Related
- 1991-08-20 DK DK91918058.8T patent/DK0550635T3/da active
- 1991-08-20 JP JP3517076A patent/JPH0772175B2/ja not_active Expired - Fee Related
- 1991-08-20 WO PCT/US1991/005776 patent/WO1992006079A1/en not_active Application Discontinuation
- 1991-08-20 ES ES91918058T patent/ES2071334T3/es not_active Expired - Lifetime
- 1991-08-20 HU HU9300898A patent/HUT68667A/hu unknown
- 1991-08-20 AT AT91918058T patent/ATE121389T1/de not_active IP Right Cessation
- 1991-08-20 BR BR919106905A patent/BR9106905A/pt not_active Application Discontinuation
- 1991-08-20 CA CA002089736A patent/CA2089736A1/en not_active Abandoned
- 1991-08-20 DE DE69109125T patent/DE69109125T2/de not_active Expired - Fee Related
- 1991-08-23 TW TW080106710A patent/TW199144B/zh active
- 1991-09-19 IL IL99525A patent/IL99525A0/xx unknown
- 1991-09-26 PT PT99064A patent/PT99064A/pt not_active Application Discontinuation
- 1991-09-26 MX MX9101274A patent/MX9101274A/es unknown
- 1991-09-27 IE IE339691A patent/IE66042B1/en not_active IP Right Cessation
- 1991-09-27 ZA ZA917744A patent/ZA917744B/xx unknown
- 1991-09-27 CN CN91109446A patent/CN1060285A/zh active Pending
- 1991-09-27 YU YU159291A patent/YU159291A/sh unknown
-
1993
- 1993-03-26 FI FI931370A patent/FI931370A/fi not_active Application Discontinuation
- 1993-03-26 NO NO93931151A patent/NO931151L/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP0550635A1 (de) | 1993-07-14 |
ZA917744B (en) | 1993-03-29 |
PT99064A (pt) | 1992-08-31 |
AU651145B2 (en) | 1994-07-14 |
IE913396A1 (en) | 1992-04-08 |
DK0550635T3 (da) | 1995-09-04 |
ATE121389T1 (de) | 1995-05-15 |
NO931151D0 (no) | 1993-03-26 |
BR9106905A (pt) | 1993-08-17 |
CZ387492A3 (en) | 1994-02-16 |
CN1060285A (zh) | 1992-04-15 |
EP0550635B1 (de) | 1995-04-19 |
JPH0772175B2 (ja) | 1995-08-02 |
DE69109125T2 (de) | 1995-09-28 |
FI931370A0 (fi) | 1993-03-26 |
ES2071334T3 (es) | 1995-06-16 |
HU9300898D0 (en) | 1993-06-28 |
DE69109125D1 (de) | 1995-05-24 |
CA2089736A1 (en) | 1992-03-29 |
IE66042B1 (en) | 1995-12-13 |
TW199144B (de) | 1993-02-01 |
YU159291A (sh) | 1994-01-20 |
MX9101274A (es) | 1992-05-04 |
AU8746391A (en) | 1992-04-28 |
HUT68667A (en) | 1995-07-28 |
WO1992006079A1 (en) | 1992-04-16 |
IL99525A0 (en) | 1992-08-18 |
JPH06501267A (ja) | 1994-02-10 |
FI931370A (fi) | 1993-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO931151L (no) | Fremgangsmaate for fremstilling av nitrogenholdige heterocykliske forbindelser med kondenserte ringer | |
GR3026231T3 (en) | 3-aminopiperidine derivatives and related nitrogen containing heterocycles. | |
FI941212A0 (fi) | Fuusioituneet trisykliset, typpeä sisältävät heterosykliset yhdisteet | |
BR1100086A (pt) | Derivados de fluoralcóxibenzilamino de heterocìclos contendo nitrogênio | |
MY105438A (en) | 3-aminopiperidine derivatives and related nitrogen containing heterocycles. | |
EA200100970A1 (ru) | Аминопроизводные как ингибиторы протеазы | |
ES2111930T3 (es) | Antagonistas del acido amp y procedimientos de tratamiento con la ayuda de estos. | |
ES8604843A1 (es) | Un metodo para la preparacion de un derivado de acetileno | |
PT92494A (pt) | Processo para a preparacao de novos derivados do indol | |
RU94019331A (ru) | Конденсированные трициклические азотсодержащие гетероциклы, фармацевтическая композиция, способ лечения |